CRV (Charles River Ventures) — 2015 Investments
5 investments dated 2015 · listed companies and verified rows first · show all
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon, US
Riley Ennis(Founder)inCharles Roberts(Founder)inGabriel Otte(Founder)inAdam Stone(Chief Executive Officer and Director)Michael Altman(Chief Business Officer and Director)Shmuel (Sam) M. Cohn(Chief Financial Officer)
Co-investorsRA CapitalAgent CapitalAME Cloud VenturesAndreessen HorowitzArtis VenturesAsset Management Company+15 more
Iterable provides customer communication and engagement software that enables brands to create targeted messaging experiences across email, SMS, push, and other channels.
AI & Machine LearningEnterprise SoftwareMarketing TechMedia & EntertainmentSaaSSan Francisco, US
Andrew Boni(Founder)inJustin Zhu(Founder)inHaoran Zhu(Executive Officer, Director)
Board seatSabri Murat Bicer· per SEC Form D
Co-investors3Spoke Capital500 Global645 VenturesAngelPadArtisanal VenturesBrighter Capital+12 more
Westborough, US
Doron Kempel(Executive Officer, Director)
BoardMatt Murphy(Director)Bruce Sachs(Director)inKevin Comolli(Director)inDavid Lemont(Director)Paul Milbury(Director)
Co-investorsAccelKleiner PerkinsMenlo VenturesAccel-KKRMeritech Capital PartnersWaypoint Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Crushpath SystemsWave Accounting
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
















